Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

571 articles

Research Review

Showing 1–4 of 4 articles · Keyword: Artificial intelligence Clear keyword

Expert review of anti-infective therapy2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Engineering smart liposomes to combat antimicrobial resistance: from mechanistic design to clinical translation

Gawale K, Karawadiya A, Katawale S, Sawarkar S, Omri A

Antimicrobial resistance (AMR) represents a critical global health threat, surpassing the pace of discovery and clinical development of new antimicrobial agents. Therefore, innovative therapeutic strategies are urgently needed to enhance antibiotic efficacy, overcome multidrug-resistant infections, and limit…

Read the article

Beilstein journal of nanotechnology2026ReviewDrug Delivery

2. Artificial intelligence and machine learning for magnetic nanoparticles and nanocarriers in cancer imaging, drug delivery, and magnetic control: a systematic review

Yao Y, Nafo W

We reviewed artificial intelligence and machine learning in magnetic resonance imaging-visible magnetic nanoparticles, nanocarriers, and systems for imaging, drug delivery, hyperthermia, targeting, transport, and control. Using "preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020"…

Read the article

International journal of pharmaceutics2026ResearchDrug Delivery

3. A structure-based virtual screening-driven discovery pharmaceutics platform for cancer therapeutics development: FDA 505(b)(2) repurposing of netupitant as a BMX-targeted nanomedicine using quality-by-design lipid nanoparticles and model-informed PBPK translation

Singirikonda M, Patel T, Parupathi P, Nagarajan A, Patel Js, Devarakonda L, Et Al.

Bone marrow tyrosine kinase on chromosome X (BMX) is an emerging therapeutic target implicated in prostate cancer progression, metastatic disease, and resistance to current therapies; however, no selective BMX-targeted therapy has advanced to clinical development.

Read the article

Biotechnology advances2026ReviewNon-viral Gene Delivery

4. From off-target to on-demand: Precision engineering and translational evaluation of next-generation base editors

Wang W, Song J, Du Y, Zhou C, Zuo X, You G, Et Al.

Due to the increasing demand for clinical gene therapy and the limitations of current treatment methods, there is an urgent need to develop gene-editing tools that are safer, more precise, and more clinically implementable. Deaminase-based base editors have emerged as gene-editing platforms with significant…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.